• About
  • Editorial Board
    • Staff Writers
  • Advertise
  • Join Us
  • Archives
The Wellesley News -
  • News and Features
    • Professor Phillip Levine Discusses “A Problem of Fit”
      Professor Phillip Levine Discusses “A Problem of Fit”
    • CS Department shifts CS 111 course structure
      CS Department shifts CS 111 course structure
    • WAMI and WRJ host discussion on criminalization of abortion
      WAMI and WRJ host discussion on criminalization of abortion
    • News
      • News in Brief
      • Nation & World
      • President’s Corner
      • Senate Report
    • Features
      • Alumnae Spotlight
      • Eye on Science
      • Faculty Focus
      • LGBTQIA+ Column
  • Opinions
    • Why Art Basel is partially responsible for Miami’s gentrification
      Why Art Basel is partially responsible for Miami’s gentrification
    • It’s time to put traditional grading to the test
      It’s time to put traditional grading to the test
    • What can the fall of Z-library teach us about textbook accessibility?
      What can the fall of Z-library teach us about textbook accessibility?
    • Staff Editorial
    • Letters to the Editor
    • The Elephant in the Room
  • Arts
    • No image
      Pentimento’s Open Mic is Like an Old Patchwork Quilt–Worn, Yet Cozy
    • No image
      Kanye’s Antisemitism Steps on his Shoe Brand
    • Lousy Realities: Luca Guadagnino (2015)
      Lousy Realities: Luca Guadagnino (2015)
    • Arts In The News
    • Reviews
    • Music Peek
    • Books Before Boys
  • Sports and Wellness
    • Student-Athlete of October
      Student-Athlete of October
    • Athletics Update Oct. 19, 2022
      Athletics Update Oct. 19, 2022
    • The Case for Body Neutrality
      The Case for Body Neutrality
    • Athlete of the Week
    • Boston Sports Update
    • The Vegan Digest
    • The SHE Corner
  • The Wellesley Snooze
    • Top 10 Girlbosses who aren’t alumnae, but I would totally believe you if you told me they were
      Top 10 Girlbosses who aren’t alumnae, but I would totally believe you if you told me they were
    • Wendy Wellesley’s Thanksgiving Menu
      Wendy Wellesley’s Thanksgiving Menu
    • The Snooze Awards for the Best Tanners of 2022
      The Snooze Awards for the Best Tanners of 2022
  • Miscellanea
    • President’s Column: The Butterfly Effect
      President’s Column: The Butterfly Effect
    • Administrators shocked to learn that students dislike being left in dark
      Administrators shocked to learn that students dislike being left in dark
    • 50 Lies You Tell Yourself in Order to Survive Until Graduation
      50 Lies You Tell Yourself in Order to Survive Until Graduation
    • The Dose
    • The Olive Branch
    • Multimedia
      • Galleries
      • Infographics
      • Videos
By Elinor Higgins Eye on Science, FeaturesSeptember 18, 2014

Ebola vaccine trials begin testing on humans

A new Ebola vaccine was tested on humans after a successful trial on monkeys, the results of which were published in the Nature Medicine journal last week.

The vaccine, developed by the National Institutes of Health (NIH) and the Swiss biotechnology company Okairos, works by injecting genetic fragments of Ebola into healthy cells. Though this may sound dangerous, the genetic fragments have been altered so that the reproduction mechanism in a normal Ebola virion is shut down.  According to the NIH, the genes simply lead to the production of a protein, which triggers a response from the immune system.

According to researchers, the trial conducted on monkeys was a success, and the monkeys were protected from the Ebola virus for up to 10 months. No other attempt at the vaccine has been this successful.

The human trials will be conducted on healthy adults at the NIH Clinical Center in Bethesda, Maryland. Twenty volunteers will be injected with the vaccine in the first round of the trial. If all goes well, some results will be obtained by the end of 2014.

In the meantime, Ebola continues to rage in West Africa, particularly in Guinea, Liberia and Sierra Leone. As of Sept. 10, 4,846 cases and 2,375 deaths have been reported by the World Health Organization (WHO) and the Centers for Disease Control (CDC), putting the current death rate at about 50 percent.

Because the virus is spread by bodily fluids, there is widespread concern for doctors and people working with those who are infected. The lack of a “tried and true” vaccine makes the virus a global concern as there is currently no approved way to stop the spread of the disease.

In fact, Sierra Leone has called for a nationwide lockdown from Sept. 19 through Sept. 21.  As people stay in their homes, health workers can quarantine new cases without fearing that the disease will be spreading faster than they can find it.

Unfortunately, Sierra Leone does not have the law enforcement capacity to ensure that the country’s six million inhabitants will stay home for the three-day lockdown, so it is expected to be fairly voluntary.

Assuming the initial trials go well, the vaccine may be released to the most desperate countries even in the experimental form. Though this is not ideal because of possible side effects, most people agree that this is a necessary step given the high death rate of the virus.

Groups like WHO are calling for this “fast-track” plan to effectively contain the imminent threat of the Ebola virus.  According to NPR, other possible therapies and vaccines are being considered, including the use of blood from those who have survived the virus to trigger an immune response similar to the one created by the vaccine.

With so much research being done to contain and eventually end the Ebola epidemic, hope for West African countries and the rest of the world is beginning to emerge.

Share on

  • Facebook
  • Twitter
  • Pinterest
  • Google +
  • LinkedIn
  • Email
Previous articleOptimizing your first-year roommate experience
Next articleLocal Textbook Walks Out of Clapp Library

You may also like

Professor Phillip Levine Discusses “A Problem of Fit”

CS Department shifts CS 111 course structure

WAMI and WRJ host discussion on criminalization of abortion

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Email Newsletter

Sign up to receive our weekly digest in your inbox

* indicates required

Top Articles

Sorry. No data so far.

Recent Tweets

Tweets by @Wellesley_News

The independent student newspaper of Wellesley College since 1901.

Sign up to receive our weekly digest in your inbox

* indicates required

  • About
  • Editorial Board
    • Staff Writers
  • Advertise
  • Join Us
  • Archives
COPYRIGHT © 2023 THE WELLESLEY NEWS
Back to top